Navigation Links
Beaumont Patients 1st to get Next Generation of Radiation Treatment
Date:9/20/2007

ROYAL OAK, Mich., Sept. 20 /PRNewswire/ -- Cancer patients at Beaumont Hospitals are the first in the world to be treated with the next generation of radiation therapy that is painless, faster, more accurate and precise than other treatments.

Beaumont doctors and physicists invented and patented the new technology, Omnibeam(R). The $3.3-million machine is manufactured in England by Elekta, which is headquartered in Stockholm. The first patient was treated on Sept. 10.

The painless treatment takes about 20 minutes and requires no implants or invasive procedures to prepare for therapy. It can be used to treat cancer of the breast; prostate; lungs; and head and neck, as well as other cancers. It is specially designed for the treatment of tumors deep within the body.

Omnibeam(R), a robotic technology, uses highly accurate, real-time CT imaging that automatically adjusts the radiation field during treatment to account for a patient's external movements - and the natural repositioning of internal organs - from day to day or even moment to moment. Omnibeam(R) also uses robotic technology to adjust the treatment table on which a patient lies to provide pinpoint accuracy of treatment. Adjusting the radiation field and treatment table means the radiation treatment is precisely targeted to kill cancer cells, destroying them without harming surrounding healthy tissue or organs. The patient has better cancer control and fewer undesirable side effects as a result.

"Omnibeam(R) is a dramatic new clinical advance in radiation therapy for cancer. The combination of improved imaging coupled with robotic technology is vastly better than other radiation machines for cancer therapy," says Alvaro Martinez, M.D., corporate chairman of Radiation Oncology for Beaumont Hospitals. "It uses advanced imaging technology, is faster, can treat from very small to very large, irregularly shaped tumors and does not require placement of metal implants as with other thera
'/>"/>

SOURCE William Beaumont Hospitals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
2. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
3. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
4. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
5. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
6. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
7. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
8. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
9. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
10. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
11. Skin Rash Actually Signifies Better Outcomes for Pancreatic and Lung Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015 The Medical ... featured in the American Medical Group Association,s "High ... AMGA,s "High Performing Health" production is ... facing the nation,s healthcare system in delivering better ... profiled along with other leading organizations in the ...
(Date:3/31/2015)... -- RnRMarketResearch.com adds "Pemphigus - Pipeline ... 68 pages with latest updates, data and information ... The report "Pemphigus - Pipeline Review, H1 2015" report provides ... Pemphigus , complete with comparative analysis at various ... action (MoA), route of administration (RoA) and molecule ...
(Date:3/31/2015)... 31, 2015  Mark Farrah Associates (MFA), ... (MA) plans in their recent analysis brief.  According ... enrolled in Medicare Advantage plans as of March ... members year-over-year.  54.3 million people are eligible for ... Medicaid Services (CMS), with an unpenetrated market of ...
Breaking Medicine Technology:AMGA's High Performing Health News Program Features The Medical Letter 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4Medicare Advantage Enrollment Reaches 17 Million According to Mark Farrah Associates 2
... NEW YORK, Oct. 13, 2011 Techstreet, ... providing corporate subscriptions to the International Society for Pharmaceutical ... publications it currently offers. The online subscription service is ... it provides unlimited access to the latest ISPE Documents ...
... 2011 K-V Pharmaceutical Company (the "Company") (NYSE: ... and Gynecologists (ACOG) and Society for Maternal-Fetal Medicine ... healthcare providers, patients, and the payer community have ... emphasizes that previous ACOG and SMFM statements regarding ...
Cached Medicine Technology:Techstreet and the ISPE Extend Partnership to Expedite Drug Research with Subscription Offering for Life Science Engineers 2K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 2K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 3K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 4K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 5K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 6K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 7K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 8
(Date:3/31/2015)... More than 120 of the world’s ... their shared support for the same basic theme of ... Health Coalition' and a lifestyle medicine initiative known as ... that, despite appearances to the contrary, there is in ... theme of healthful eating and living. , ...
(Date:3/31/2015)... Texas (PRWEB) March 31, 2015 As a ... the value of a good teacher when it comes to ... educators for their instrumental service to the community, Metro Express ... during the summer, all area teachers can be too cool ... teachers and educators put in to help our children get ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 QMedET ... Edition 2, bringing the industry’s most advanced speech ... healthcare community. Physicians can now experience the full ... trusted source, offering value-added support services that ensure ... systems. , “QMedET is proud to provide Dragon ...
(Date:3/31/2015)... For its fourth consecutive year, Survivor Spin, an ... survivors, is hoping to raise thousands of dollars at ... Center for Fitness (LCF) in Maywood, IL. ... the LCF, Nicole Capone, launched the Survivor Spin Relay in ... in a fun-filled evening of friendly indoor cycling competition accompanied ...
(Date:3/31/2015)... New York, New York (PRWEB) March 31, 2015 ... Parkinson Disease Association (APDA) is proud to announce 30 Days, ... to learn about this month-long campaign that will offer ... lasting impact in the lives of those who battle this ... new diagnosis, which means that in April alone nearly 5,000 ...
Breaking Medicine News(10 mins):Health News:GLiMMER Initiative Founder David Katz, MD Announces the Launch of the True Health Coalition: Worldwide Experts Convened to Defend Fundamentals of Healthy Eating/Living 2Health News:GLiMMER Initiative Founder David Katz, MD Announces the Launch of the True Health Coalition: Worldwide Experts Convened to Defend Fundamentals of Healthy Eating/Living 3Health News:GLiMMER Initiative Founder David Katz, MD Announces the Launch of the True Health Coalition: Worldwide Experts Convened to Defend Fundamentals of Healthy Eating/Living 4Health News:Metro Express Service Launches Educator Discount Program to DFW Teachers 2Health News:QMedET Solutions Announces Addition of Dragon® Medical Practice Edition 2 to its Roster of Products 2Health News:Upcoming Survivor Spin Relay Fundraiser Hopes to Raise Thousands of Dollars for Cancer Patients 2Health News:Upcoming Survivor Spin Relay Fundraiser Hopes to Raise Thousands of Dollars for Cancer Patients 3Health News:Join The American Parkinson Disease Association to Commemorate April Parkinson's Awareness Month 2Health News:Join The American Parkinson Disease Association to Commemorate April Parkinson's Awareness Month 3
... finds, , , , WEDNESDAY, May 27 (HealthDay News) -- ... identified by U.S. researchers, who said their finding could ... researchers, from the Washington University School of Medicine in ... gene in tumors boosts the risk of cancer recurrence ...
... single session; patient goes home that same dayPALO ALTO, ... powerful non-invasive radiosurgery treatment, John Sisco, 64, happily walked ... an overnight stay in the hospital, and left for ... New Jersey, used the advanced Novalis Tx(TM) platform from ...
... Expedite Immediate Hurricane ResponseCHICAGO, May 27 Feeding ... the global health care company, Abbott, to pre-position ... Southeast United States and Puerto Rico in preparation ... on June 1. Feeding America is the ...
... Leaders Launch ignite09 to Improve Health Outcomes and ... for Cost-Effective Consumerism, the American Benefits Council and ... policy organizations are bringing together leaders in innovation ... symposium on the convergence of behavioral economics and ...
... Submits Comments on REMS; Leaders in Pain Research and Treatment ... , , GLENVIEW, Ill., May 27 As ... this week on Risk Evaluation and Mitigation Strategy (REMS), physician ... (AAPM), the premiere medical association for physicians and ...
... - Dillon to Lead Effort ... Powerful Analytics , Elsevier, ... announced today that Chris Dillon has joined Elsevier ... Support (CDS) group.,Dillon will assume responsibility for all ...
Cached Medicine News:Health News:Gene Mutation May Up Risks of Endometrial Cancer 2Health News:New Jersey Doctors Now Delivering Non-Invasive, Image-Guided Radiosurgery Treatments Using Novalis Tx(TM) Technology 2Health News:New Jersey Doctors Now Delivering Non-Invasive, Image-Guided Radiosurgery Treatments Using Novalis Tx(TM) Technology 3Health News:New Jersey Doctors Now Delivering Non-Invasive, Image-Guided Radiosurgery Treatments Using Novalis Tx(TM) Technology 4Health News:Feeding America and Abbott Partner For Hurricane Relief 2Health News:Feeding America and Abbott Partner For Hurricane Relief 3Health News:Key Stakeholders Convene Capitol Hill Symposium To Advance Convergence of Behavioral Economics and Healthcare 2Health News:Key Stakeholders Convene Capitol Hill Symposium To Advance Convergence of Behavioral Economics and Healthcare 3Health News:Key Stakeholders Convene Capitol Hill Symposium To Advance Convergence of Behavioral Economics and Healthcare 4Health News:Key Stakeholders Convene Capitol Hill Symposium To Advance Convergence of Behavioral Economics and Healthcare 5Health News:Pain Medicine Experts Recommend Monitoring, Education for All Opioid Medicines 2Health News:Elsevier Appoints Chris Dillon as Managing Director, Clinical Decision Support 2Health News:Elsevier Appoints Chris Dillon as Managing Director, Clinical Decision Support 3
... of some micro vascular clamps can be ... use, Stainless steel changes its elasticity, causing ... pressures above 30g/mm2 may be associated with ... titanium which does not change its elasticity ...
... daylight into the surgical suite with the ... a variety of applications - including use ... - this light source delivers instant clean ... for superb tissue definition, even in hard-to-see ...
Designed for simple operation, the Model 515C pulse oximeter is ideal for use in any clinical setting; from emergency hospital transport to continuous monitoring in Anesthesia, Intensive Care and Gen...
... The Models 512 and 513 ... processing. This advanced technology is able ... higher resolutions and speeds of 100 ... results in improved pulse oximeter performance ...
Medicine Products: